LEXINGTON, MASSACHUSETTS, U.S.A., February 16, 2009 — RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, has appointed Patrick Kelly to the newly created position of European Sales Director, effective immediately.
“Mr. Kelly’s appointment represents an important step in the geographic expansion of our commercial efforts with the first quarter release of our Sequence Enrichment Solution for the targeted sequencing of the human genome,” said Stephen E. Becker, Vice President, Commercial Operations, RainDance Technologies. “His international business experience in life sciences and genetics and sequencing makes him the ideal candidate to lead RainDance’s entry into the European market.”
Based in Manchester, England, Mr. Kelly will be responsible for introducing RainDance’s RainStorm™ technology platform to Europe. He will work with thought leaders in genomics research to adopt RainDance’s Sequence Enrichment Solution and the RDT 1000 instrument. In addition, Mr. Kelly will build the commercial sales infrastructure required to launch the company’s solutions in the European market.
Mr. Kelly joins RainDance from Helicos Biosciences where he served as Global Business Manager for the company’s European operations. In this role, he led the positioning of the company’s next-generation sequencing technology with opinion leaders in the region. Mr. Kelly previously was Business Team Manager, Europe, Middle East, Africa, for Agilent Technologies. He also was European Site Manager and Vice President, Sales and Support, for Affymetrix Europe, where he led commercial activities for microarray systems and reagents in the research, pharmaceutical, and molecular diagnostics markets, and served as European Sales Manager for genetic analysis systems at Applied Biosystems. Mr. Kelly received a Bachelor of Science degree in Chemistry from Sheffield University and is a member of the Institute of Directors (UK).
About RainDance Technologies
RainDance Technologies is pioneering the use of high-throughput microdroplet-based analysis in human health and life science research. The company’s core RainStorm™ technology generates millions of discrete droplets that can encapsulate a single molecule, cell or reaction and be digitally analyzed and sorted one at a time. The power, precision and simplicity of microdroplets enable researchers to answer complex questions with unprecedented sensitivity and quantitation. The complete RainDance solution includes automated instrumentation, customizable bioinformatics and high-value consumables and reagents for applications including targeted next-generation DNA sequencing, methylation, digital PCR and single cell analysis. Based in Lexington, Massachusetts, the company supports scientists around the world through its international sales and support operations and a global network of distributors and service providers. For more information, please visit www.RainDanceTech.com.
RainDance, RainStorm, ThunderStorm, Digital Biology are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.
